Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

被引：0
|
作者：
Putra, J. [1 ]
Schiano, T. [2 ]
Fiel, M. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Pathol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
150
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [1] Histologic Assessment of HCV Liver Transplant Recipients with Sustained Virologic Response After Treatment with Direct-Acting Antiviral Agents
    Putra, Juan
    Schiano, Thomas D.
    Fiel, M. Isabel
    LABORATORY INVESTIGATION, 2017, 97 : 422A - 422A
  • [2] Histologic Assessment of HCV Liver Transplant Recipients with Sustained Virologic Response After Treatment with Direct-Acting Antiviral Agents
    Putra, Juan
    Schiano, Thomas D.
    Fiel, M. Isabel
    MODERN PATHOLOGY, 2017, 30 : 422A - 422A
  • [3] Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Enomoto, Masaru
    Murakami, Yoshiki
    Kawada, Norifumi
    GASTROENTEROLOGY, 2017, 153 (01) : 327 - 328
  • [4] Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction? Reply
    Kahn, Jeffrey
    Saito, Takeshi
    GASTROENTEROLOGY, 2017, 153 (01) : 328 - 329
  • [5] HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
    Gaetano La Manna
    Journal of Nephrology, 2018, 31 : 185 - 187
  • [6] HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
    La Manna, Gaetano
    JOURNAL OF NEPHROLOGY, 2018, 31 (02) : 185 - 187
  • [7] Changing Population of Liver Transplant Recipients in the Era of Direct-acting Antiviral Therapy
    Xie, Chencheng
    Kuo, Yong-Fang
    Singal, Ashwani K.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2020, 8 (03) : 262 - 266
  • [8] Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients
    Nogueras Lopez, F.
    Lopez Garrido, A.
    Ortega Suazo, E. J.
    Vadillo Galles, F.
    Valverde Lopez, F.
    Espinosa Aguilar, M. D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 631 - 633
  • [9] "Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era
    Cotter, Thomas G.
    Wang, Jennifer
    Lieber, Sarah R.
    Odenwald, Matthew A.
    Rich, Nicole E.
    Marrero, Jorge A.
    Singal, Amit G.
    Mitchell, Mack C.
    Aronsohn, Andrew
    Charlton, Michael
    Fung, John
    TRANSPLANTATION DIRECT, 2021, 7 (07): : E707
  • [10] Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents
    Suraweera, Duminda
    Saab, Elena G.
    Tong, Myron J.
    Saab, Sammy
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (03) : 243 - 251
12345